KITLG and myelodysplastic syndrome: To clarify which substrates are more likely to be direct targets of the SCF-FBXO11 complex, we performed co-IP of FBXO11 complexes in F-36P cells (26), established from a patient with MDS-refractory anemia with excess blasts that had progressed to AML.